课题基金 / 基金详情

项目摘要

项目成果

Heidi Stuhlmann的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):血管生成和血管生成由一个复杂的生长因子及其同源受体系统控制。其中包括血管内皮生长因子/血管内皮生长因子受体和血管生成素/Tie信号通路,以及b-成纤维细胞生长因子、转化生长因子-β、肾上腺素及其受体。此外,还阐明了Notch信号在血管发育和动静脉命运调控中的重要性。虽然这些途径对血管发育的重要性已有文献记载,但其他关键因素可能仍未确定。利用“基因陷阱”的方法,我们最近发现了Egfl7,一个新的内皮限制基因,它编码一个分泌性蛋白,带有一个EMI结构域,两个EGF结构域,以及在Notch配体中发现的一个可能的DSL结构域。Egfl7在卵黄囊血岛中的新生血管及其祖细胞中特异表达。在成年人中,Egfl7在血管生成和动脉损伤过程中表达上调。我们的初步研究表明,EGFL7在体外与Notch 1和4结合,并介导几种已知的Notch效应器功能。在目前的提案中,我们将检验这样的假设,即EGFL7是Notch的新配体,EGFL7作为Notch激动剂发挥作用,并且EGFL7诱导的Notch信号在血管发育和血管生成过程中介导独特的和非冗余的过程。我们将在原代人内皮细胞中测试这些假说,并在ES细胞体外分化系统和小鼠中使用获得和功能丧失的方法。我们提出了以下目标:目标1:确定EGFL7在HUVEC和鸡绒毛膜尿囊膜模型中Notch信号转导中的作用。目的2:确定内皮细胞中Egfl7的过度表达是否导致血管发育缺陷。我们将通过产生Tie2-Egfl7转基因小鼠来强迫Egfl7在内皮细胞中表达,并通过产生VE-Caherin:TTA;tre-Egfl7转基因小鼠来诱导内皮细胞中Egfl7的表达。目的3:检测Egfl7功能是否在血管发育的早期阶段起关键作用。我们将在ES细胞和小鼠胚胎中培育出具有条件敲除等位基因和基于慢病毒的siRNA敲除的小鼠。
英文摘要
DESCRIPTION (provided by applicant): Vasculogenesis and angiogenesis are controlled by a complex system of growth factors and their cognate receptors. These include VEGF/VEGFR and angiopoietin/Tie signaling pathways, as well as b-FGF, TGF-beta, ephrins, and their receptors. In addition, the importance of Notch signaling for vascular development and arterial-venous fate specification has been elucidated. While the importance of these pathways for vascular development has been documented, it is likely that other critical factors remain unidentified. Using a "gene trap" approach, we recently identified Egfl7, a novel endothelial-restricted gene that encodes a secreted protein with an EMI domain, two EGF domains, and a putative DSL domain found in Notch ligands. Egfl7 is specifically expressed in the emerging vasculature and its progenitors in the yolk sac blood islands. In adults, Egfl7 is up-regulated during angiogenesis and arterial injury. Our preliminary studies indicate that EGFL7 binds to Notch 1 and 4 in vitro and mediates several of the known Notch effector functions. In the present proposal, we will test the hypothesis that EGFL7 is a novel ligand for Notch, that EGFL7 functions as a Notch agonist, and that EGFL7-induced Notch signaling mediates distinctive and non-redundant processes during vascular development and angiogenesis. We will test these hypotheses in primary human endothelial cells, and by using gain- and loss-of-function approaches in an ES cell in vitro differentiation system and in mice. We are proposing the following aims: Aim 1: Determine the role of EGFL7 in Notch signaling in HUVEC and in a chick chorioallantoic membrane model. Aim 2: Determine whether overexpression of Egfl7 in the endothelium leads to defects in vascular development. We will force expression of Egfl7 in endothelial cells by generating Tie2-Egfl7 transgenic mice, and induce Egfl7 expression in endothelial cells by generating VE-Cadherin:tTA;TRE-Egfl7 transgenic mice. Aim 3: Test whether Egfl7 function is crucial for early stages of vascular development. We will generate mice with a conditional knock-out allele and lentivirus-based siRNA knock-down in ES cells and mouse embryos.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Training Program in Developmental and Stem Cell Biology
Training Program in Developmental Biology
Training Program in Developmental Biology
Training Program in Developmental Biology
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    乔安娜
  • 依托单位: